Highlights
- Andromeda Metals produced pilot-scale alumina samples with measured purity up to 99.9989%, advancing its customer evaluation and development program.
- An inaugural sample was sent to Japan, with further customer samples expected during the final quarter of 2026.
- Great White funding discussions continue, with approximately AUD 40 million of indicative Equity funding required alongside a conditional Debt facility.
- September cash reached AUD 4.302 million after a Capital raising, while commercial scale-up and customer qualification remain outstanding tasks.
Andromeda Metals Limited (ASX:ADN) is developing kaolin and high-purity alumina projects using Great White feedstock in South Australia. Its shares traded at AUD 0.006, up 20%, on 17 November 2026. Pilot-scale alumina production and customer sampling provide its latest technical progress, while financing remains central to the separate Great White development pathway.
Pilot Results Advance Customer Evaluation
The 29 October update reported independent analysis of three samples from the continuous pilot plant. Two recorded measured alumina purity of 99.9989%, while the third returned 99.9986%.
A more conservative calculation incorporating reporting limits for elements below detection also confirmed purity above the 4N threshold of 99.99%. The results relate to pilot samples and should remain distinct from sustained commercial Manufacturing performance.
The first sample was sent to a prospective Japanese customer in high-technology manufacturing. Additional samples were being prepared for evaluation during the remainder of the December quarter. Customer feedback is expected to inform product optimisation and market selection, rather than represent a completed Supply agreement.
Process Data Supports The Next Study
The pilot program is collecting engineering and operating information for a planned pre-feasibility study. Work includes flowsheet optimisation, assessment of operating parameters and production of both amorphous and crystalline alpha-alumina samples.
Potential co-products, including amorphous silica, are also being assessed. Their characteristics and possible applications require further work before any additional commercial value can be established.
Andromeda received its first Patent for the proprietary alumina process in South Africa, with applications continuing elsewhere. A non-binding heads of agreement with Traxys North America provides a potential route for US customer engagement. Its non-binding status remains relevant when assessing the certainty of future sales.
Great White Still Requires A Funding Decision
Pre-construction early works at Great White have been completed, and the remaining filter press components arrived in Australia and were moved into storage. Management describes the project as development-ready.
The September report estimated approximately AUD 40 million of remaining equity funding for Stage 1A+, alongside a credit-approved AUD 75 million Merricks Capital debt facility. The equity estimate is indicative, while final debt approvals and binding execution depend on completing the funding package.
Discussions extend beyond conventional Equity Financing to strategic and corporate alternatives. Equipment readiness does not remove the need for a final Investment decision and an executable financing structure before construction proceeds.
Cash And Execution Define The Near-Term Outlook
Cash increased to AUD 4.302 million at 30 September from AUD 3.196 million at June-end, following an AUD 3.04 million raising before costs. Quarterly operating and investing outflows were approximately AUD 1.358 million and AUD 436,000 respectively.
The company continued measures to conserve cash and announced board and management changes on 30 October. Its operational priorities remain pilot optimisation, customer sample evaluation, preparation for the alumina pre-feasibility study and resolution of Great White funding.
Technical scale-up, customer acceptance and access to capital remain material uncertainties. Market Capitalisation was AUD 30.85 million on 17 November, with the shares down 50% over one year despite the day’s gain.






Please wait processing your request...